Agarwal Shefali 4
4 · FATE THERAPEUTICS INC · Filed Jun 11, 2024
Insider Transaction Report
Form 4
Agarwal Shefali
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-07+40,000→ 40,000 totalExercise: $3.68Exp: 2034-06-07→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders.
- [F2]The shares subject to this option shall vest and become exercisable on the earlier of (i) June 7, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.